These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 33642251)

  • 21. Acceptance of digital health applications in non-pharmacological therapies in German statutory healthcare system: Results of an online survey.
    Frey S; Kerkemeyer L
    Digit Health; 2022; 8():20552076221131142. PubMed ID: 36506488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physicians' Attitudes Toward Prescribable mHealth Apps and Implications for Adoption in Germany: Mixed Methods Study.
    Dahlhausen F; Zinner M; Bieske L; Ehlers JP; Boehme P; Fehring L
    JMIR Mhealth Uhealth; 2021 Nov; 9(11):e33012. PubMed ID: 34817385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Telemonitoring and eHealth for arterial hypertension : Status quo and perspectives].
    Beger C; Haller H; Limbourg FP
    Internist (Berl); 2021 Mar; 62(3):263-268. PubMed ID: 33580308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benefit Assessment and Reimbursement of Digital Health Applications: Concepts for Setting Up a New System for Public Coverage.
    Lantzsch H; Panteli D; Martino F; Stephani V; Seißler D; Püschel C; Knöppler K; Busse R
    Front Public Health; 2022; 10():832870. PubMed ID: 35530738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Technology assessment of digital health applications for reimbursement decisions].
    Jeindl R; Wild C
    Wien Med Wochenschr; 2024 Mar; 174(3-4):44-52. PubMed ID: 34529150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Critical success factors for creating sustainable digital health applications: A systematic review of the German case.
    Schramm L; Carbon CC
    Digit Health; 2024; 10():20552076241249604. PubMed ID: 38665883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methods for the comparative evaluation of pharmaceuticals.
    Zentner A; Velasco-Garrido M; Busse R
    GMS Health Technol Assess; 2005 Nov; 1():Doc09. PubMed ID: 21289930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postmarketing Follow-Up of a Digital Home Exercise Program for Back, Hip, and Knee Pain: Retrospective Observational Study With a Time-Series and Matched-Pair Analysis.
    Teepe GW; Kowatsch T; Hans FP; Benning L
    J Med Internet Res; 2023 Feb; 25():e43775. PubMed ID: 36848211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Access and reimbursement pathways for digital health solutions and
    Mantovani A; Leopaldi C; Nighswander CM; Di Bidino R
    Front Med Technol; 2023; 5():1101476. PubMed ID: 36891483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Assessing the benefits of digital health solutions in the societal reimbursement context].
    Albrecht UV; Kuhn B; Land J; Amelung VE; von Jan U
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2018 Mar; 61(3):340-348. PubMed ID: 29368121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effectiveness of internet-based e-learning on clinician behavior and patient outcomes: a systematic review protocol.
    Sinclair P; Kable A; Levett-Jones T
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):52-64. PubMed ID: 26447007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Digital health applications (DiGA): assessment of reimbursability by means of the "DiGA Fast Track" procedure at the Federal Institute for Drugs and Medical Devices (BfArM)].
    Lauer W; Löbker W; Höfgen B
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2021 Oct; 64(10):1232-1240. PubMed ID: 34529095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Covering digital health applications in the public insurance system: how to foster innovation in patient care while mitigating financial risks-evidence from Germany.
    Groene N; Schneck L
    Front Digit Health; 2023; 5():1217479. PubMed ID: 37886669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Digitalization of healthcare and its effects on quality of care].
    Brönneke JB; Debatin JF
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2022 Mar; 65(3):342-347. PubMed ID: 35181795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Digital health applications and the fast-track pathway to public health coverage in Germany: challenges and opportunities based on first results.
    Lantzsch H; Eckhardt H; Campione A; Busse R; Henschke C
    BMC Health Serv Res; 2022 Sep; 22(1):1182. PubMed ID: 36131288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
    Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
    Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Practical use of digital health applications (DiGA) in internal medicine].
    Mittermaier M; Sina C; Richter JG; Raspe M; Stais P; Vehreschild J; Wolfrum S; Anthes C; Möckel M;
    Internist (Berl); 2022 Mar; 63(3):245-254. PubMed ID: 35037948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Experiences of digital health care applications (DIGA) manufacturers with the BfArM Fast-Track procedure].
    Heimann P; Lorenz N; Blum N; Schifferings C
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2021 Oct; 64(10):1249-1253. PubMed ID: 34542649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Germany's digital health reforms in the COVID-19 era: lessons and opportunities for other countries.
    Gerke S; Stern AD; Minssen T
    NPJ Digit Med; 2020; 3():94. PubMed ID: 32685700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequential multiple assignment randomization trial designs for nursing research.
    Doorenbos AZ; Haozous EA; Jang MK; Langford D
    Res Nurs Health; 2019 Dec; 42(6):429-435. PubMed ID: 31599468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.